表紙
市場調査レポート

世界の血糖値モニタリング装置市場

Global BGM Device Market 2014-2018

発行 TechNavio (Infiniti Research Ltd.) 商品コード 250526
出版日 ページ情報 英文 82 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.71円で換算しております。
Back to Top
世界の血糖値モニタリング装置市場 Global BGM Device Market 2014-2018
出版日: 2014年11月05日 ページ情報: 英文 82 Pages
概要

世界の血糖値モニタリング装置市場は、2013年から2018年にかけて、5.26%のCAGRで拡大する見込みです。

当レポートでは、世界における血糖値モニタリング装置市場の動向や将来予測、成長因子と課題、主要ベンダーの分析などの情報を提供しています。

第1章 エグゼクティブサマリー

第2章 略語リスト

第3章 調査範囲

  • 市場概要
  • 主な製品

第4章 市場調査手法

  • 市場調査プロセス
  • 調査手法

第5章 イントロダクション

第6章 市場情勢

  • 市場概要
  • 市場規模と予測
  • ファイブフォース分析

第7章 罹患率と有病率

  • 糖尿病患者の治療方法

第8章 製品別の市場区分

  • 検査紙
  • 血糖値メーター
  • ランセット

第9章 地理区分

  • 南北アメリカ
  • 欧州・中東・アフリカ地域
  • アジア太平洋地域

第10章 購入基準

第11章 市場成長因子

第12章 成長因子とその影響

第13章 市場の課題

第14章 成長因子と課題の影響

第15章 市場動向

第16章 動向とその影響

第17章 ベンダー情勢

  • 競合シナリオ
    • 主なニュース
    • M&A
  • 市場シェア分析
  • その他の有力ベンダー

第18章 主要ベンダーの分析

  • Abbott Laboratories
  • Arkray
  • Bayer HealthCare
  • F. Hoffmann-La Roche
  • LifeScan

第19章 関連レポート

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: IRTNTR4487

About Blood Glucose Monitoring (BGM)

Diabetes is a disease that occurs when the body is unable to produce insulin, or when the glucose rises above the required levels. Insulin, a hormone produced by the pancreas, is used to process glucose, which acts as a fuel for the tissues. BGM is the process of testing the concentration of insulin or glucose in the blood. A blood glucose meter is a small electronic device used to measure and display the blood glucose level. To measure the level of blood glucose, a small drop of blood is taken by pricking a finger with an instrument called a lancet. The blood is then placed on a disposable blood glucose test strip and this is inserted into a blood glucose meter.

TechNavio's analysts forecast the Global Blood Glucose Monitoring Device market to grow at a CAGR of 5.26 percent over the period 2013-2018.

Covered in this Report

The Global Blood Glucose Monitoring market can be divided into three segments: Blood Glucose Strips, Blood Glucose Meters, and Lancets. This report covers the present scenario and the growth prospects of the Global Blood Glucose Monitoring Device market for the period 2013-2018. To calculate the market size, the report considers the revenue generated from the sales of the three segments as mentioned below.

  • Blood Glucose Strips
  • Blood Glucose Meters
  • Lancets

TechNavio's report, the Global Blood Glucose Monitoring Device Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Blood Glucose Monitoring Device market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • EMEA
  • APAC

Key Vendors

  • Abbott Laboratories
  • Arkray
  • Bayer Healthcare
  • F. Hoffmann-La Roche
  • LifeScan

Other Prominent Vendors

  • B. Braun Melsungen
  • Bionime
  • DexCom
  • GlySens
  • Medtronic
  • Nipro Diagnostics
  • Nova Biomedical
  • Terumo Europe

Market Driver

  • Increase in Diabetic Patients
  • For a full, detailed list, view our report

Market Challenge

  • High Cost of Blood Glucose Monitoring Devices
  • For a full, detailed list, view our report

Market Trend

  • Increased Adoption of Home Healthcare Devices
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be
  • What are the key market trends
  • What is driving this market
  • What are the challenges to market growth
  • Who are the key vendors in this market space
  • What are the market opportunities and threats faced by the key vendors
  • What are the strengths and weaknesses of the key vendors

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Rate of Incidence and Prevalence

Treatment Methods for Diabetic Patients

08. Market Segmentation by Products

  • 08.1. Global Blood Glucose Test Strips Market
    • 08.1.1. Market Size and Forecast
  • 08.2. Global Blood Glucose Meters Market
    • 08.2.1. Market Size and Forecast
  • 08.3. Global Lancets Market
    • 08.3.1. Market Size and Forecast

09. Geographical Segmentation

  • 09.1. BGM Device Market in the Americas
    • 09.1.1. Market Size and Forecast
  • 09.2. BGM Device Market in the EMEA Region
    • 09.2.1. Market Size and Forecast
  • 09.3. BGM Device Market in the APAC Region
    • 09.3.1. Market Size and Forecast

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Trends and their Impact

17. Vendor Landscape

  • 17.1. Competitive Scenario
    • 17.1.1. Key News
    • 17.1.2. Mergers and Acquisitions
  • 17.2. Market Share Analysis 2013
  • 17.3. Other Prominent Vendors

18. Key Vendor Analysis

  • 18.1. Abbott Laboratories
    • 18.1.1. Key Facts
    • 18.1.2. Business Overview
    • 18.1.3. Business Segmentation by Revenue
    • 18.1.4. Business Segmentation by Revenue 2011 and 2012
    • 18.1.5. Geographical Segmentation by Revenue
    • 18.1.6. Business Strategy
    • 18.1.7. Key Information
    • 18.1.8. SWOT Analysis
  • 18.2. Arkray
    • 18.2.1. Key Facts
    • 18.2.2. Business Overview
    • 18.2.3. Business Segmentation
    • 18.2.4. Recent Developments
    • 18.2.5. SWOT Analysis
  • 18.3. Bayer HealthCare
    • 18.3.1. Key Facts
    • 18.3.2. Business Overview
    • 18.3.3. Business Segmentation by Revenue 2013
    • 18.3.4. Business Segmentation by Revenue 2012 and 2013
    • 18.3.5. Geographical Segmentation by Revenue 2013
    • 18.3.6. Business Strategy
    • 18.3.7. Recent Developments
    • 18.3.8. SWOT Analysis
  • 18.4. F. Hoffmann-La Roche
    • 18.4.1. Key Facts
    • 18.4.2. Business Overview
    • 18.4.3. Business Segmentation
    • 18.4.4. Business Segmentation by Revenue 2012 and 2013
    • 18.4.5. Geographical Segmentation by Revenue
    • 18.4.6. Business Strategy
    • 18.4.7. Key Information
    • 18.4.8. SWOT Analysis
  • 18.5. LifeScan
    • 18.5.1. Key Facts
    • 18.5.2. Business Overview
    • 18.5.3. Product Segmentation
    • 18.5.4. Geographical Segmentation by Revenue 2013
    • 18.5.5. Business Strategy
    • 18.5.6. Recent Developments
    • 18.5.7. SWOT Analysis

19. Other Reports in this Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global BGM Device Market 2013-2018 (US$ million)
  • Exhibit 3: Global BGM Distribution Overview 2013
  • Exhibit 4: Global BGM Devices Market by Treatment Methods 2013
  • Exhibit 5: Global BGM Device Market Segmentation by Product
  • Exhibit 6: Blood Glucose Meters Segmentation 2013
  • Exhibit 7: Global BGM Device Market by Market Segmentation 2013
  • Exhibit 8: Global Blood Glucose Test Strips Market 2013-2018 (US$ million)
  • Exhibit 9: Global Blood Glucose Meters Market 2013-2018 (US$ million)
  • Exhibit 10: Global Lancets Market 2013-2018 (US$ million)
  • Exhibit 11: Global BGM Device Market by Product Segmentation 2013-2018 (US$ million)
  • Exhibit 12: Global BGM Device Market by Product Segmentation 2013-2018 (Percentage)
  • Exhibit 13: Global BGM Device Market by Geographical Segmentation 2013
  • Exhibit 14: BGM Device Market in the Americas 2013-2018 (US$ million)
  • Exhibit 15: BGM Device Market in the EMEA Region 2013-2018 (US$ million)
  • Exhibit 16: BGM Device Market in the APAC Region 2013-2018 (US$ million)
  • Exhibit 17: Global BGM Device Market by Geographical Segmentation 2013-2018 (US$ million)
  • Exhibit 18: Global BGM Device Market by Geographical Segmentation 2013-2018 (in percent)
  • Exhibit 19: Global BGM Device Market by Vendor Segmentation 2013
  • Exhibit 20: Abbott Laboratories Portfolio Revenue 2013
  • Exhibit 21: F. Hoffmann-La Roche Diagnostics Sales by Business Area
  • Exhibit 22: LifeScan Medical Devices and Diagnostics Sales by Major Franchise
  • Exhibit 23: Abbott Laboratories: Business Segmentation by Revenue 2012
  • Exhibit 24: Abbott Laboratories: Business Segmentation by Revenue 2011 and 2012 (US$ million)
  • Exhibit 25: Abbott Laboratories: Geographical Segmentation by Revenue 2012
  • Exhibit 26: Arkray: Business Segmentation 2013
  • Exhibit 27: Bayer HealthCare: Business Segmentation by Revenue 2013
  • Exhibit 28: Bayer HealthCare: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
  • Exhibit 29: Bayer HealthCare: Geographical Segmentation by Revenue 2013
  • Exhibit 30: F. Hoffmann-La Roche: Business Segmentation by Revenue 2013
  • Exhibit 31: F. Hoffmann-La Roche: Business Segmentation by Revenue 2012 and 2013
  • Exhibit 32: F. Hoffmann-La Roche: Revenue of Pharmaceuticals Division by Geography 2013
  • Exhibit 33: F. Hoffmann-La Roche: Revenue of Diagnostics Division by Geography 2013
  • Exhibit 34: LifeScan: Product Segmentation 2013
  • Exhibit 35: LifeScan: Geographical Segmentation by Revenue 2013
Back to Top